These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 9471869)
1. [Epidemiologic data of uro-oncologic pathology in a urology service of a university general hospital. Comments regarding cancer of the prostate]. Gelabert Mas A; Arango Toro O; Casamitjana Abella M; Galcerán JC; Griño Garreta J; Bielsa Galí O; Cortadellas Angel R; Nohales Taurines G; Herrero Polo M; Carrasco Cánovas N Actas Urol Esp; 1997 Oct; 21(9):862-7. PubMed ID: 9471869 [TBL] [Abstract][Full Text] [Related]
2. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment. Stotts RC Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183 [TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765 [TBL] [Abstract][Full Text] [Related]
5. [Detection of urological and male genital tumors diagnosed in Beijing Hospital 1995 - 2004]. Liu M; Wang JY; Zhang YG; Zhu SC; Lu ZH; Wan B Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2423-5. PubMed ID: 18036323 [TBL] [Abstract][Full Text] [Related]
6. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457 [TBL] [Abstract][Full Text] [Related]
7. Predictors for the symptomatic prostate cancer patient's delays in seeking care. Sunny L; Hopfgarten T; Adolfsson J; Steineck G Eur J Cancer; 2008 Mar; 44(5):733-9. PubMed ID: 18289844 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer: updated experience from the Tyrol study. Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158 [TBL] [Abstract][Full Text] [Related]
9. Differences between urologists in the United States and Canada in the approach to prostate cancer. Fleshner N; Rakovitch E; Klotz L J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858 [TBL] [Abstract][Full Text] [Related]
10. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy. Zietman AL; Thakral H; Wilson L; Schellhammer P J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206 [TBL] [Abstract][Full Text] [Related]
11. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model. Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395 [TBL] [Abstract][Full Text] [Related]
12. MRI in uro and gynaecological cancer. El-Diasty TA Tunis Med; 2005 Dec; 83 Suppl 12():26-7. PubMed ID: 16430063 [No Abstract] [Full Text] [Related]
13. Prostate cancer in Victoria in 1993: patterns of reported management. Frydenberg M; Giles GG; Mameghan H; Thursfield VJ; Millar J; Wheelahan JB; Bolton DM; Syme RR Med J Aust; 2000 Mar; 172(6):270-4. PubMed ID: 10860092 [TBL] [Abstract][Full Text] [Related]
14. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533 [TBL] [Abstract][Full Text] [Related]
16. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780 [TBL] [Abstract][Full Text] [Related]
17. [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004]. Flamand V; Zini L; Salleron J; Fantoni JC; Biserte J; Villers A Prog Urol; 2008 Jan; 18(1):53-9. PubMed ID: 18342157 [TBL] [Abstract][Full Text] [Related]
19. An audit of the investigation and treatment of localised prostatic cancer in the south west region. Lodge RN Ann R Coll Surg Engl; 1999 Mar; 81(2):133-8. PubMed ID: 10364974 [TBL] [Abstract][Full Text] [Related]